{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:00:56Z","timestamp":1784894456223,"version":"3.55.0"},"reference-count":127,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>In spite of at least six discrete classes of drugs available for cancer treatment, the quest for more biologic drugs continues. One type of biologic molecule that occurs naturally in the body is microRNA. MicroRNAs regulate post-transcriptional gene expression and can be under expressed in cancer (tumor suppressor microRNAs) or over expressed (oncogenic microRNAs). Strand-specific mimics of microRNAs have been developed and used successfully in vitro, in vivo, and in clinical trials, to control multiple aspects of cancer including metastasis, apoptosis and proliferation. Each microRNA is capable of binding a specific target mRNA or mRNAs, sometimes simultaneously interfering with multiple genes in a single pathway, or binding with a single nodal mRNA. Some microRNAs can facilitate chemotherapy that has stopped working, addressing the issue of drug resistance. Without chemical modification, microRNAs are too vulnerable to have lasting therapeutic value. Chemical modifications to microRNAs have provided nuclease resistance and greater stability and are the basis for microRNA mimics that can be used therapeutically. However, without a vehicle, microRNA mimics do not cross cell membranes. These nanoparticles can cause inflammatory reactions in patients. Additional modifications that enabled microRNA mimics to cross cell membranes include substituting uracil with 5-fluorouracil. Lessons from an siRNA therapeutic called Patisiran offer a roadmap for future success for microRNAs in cancer. This review provides a historical perspective of the continuing evolution of microRNA mimics for cancer treatment.<\/jats:p>","DOI":"10.3390\/biom16081086","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:38:41Z","timestamp":1784889521000},"page":"1086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Promise and Pursuit of MicroRNAs for Cancer Treatment"],"prefix":"10.3390","volume":"16","author":[{"given":"Camaleta","family":"Boothe","sequence":"first","affiliation":[{"name":"Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"},{"name":"NSU AutoNation Institute for Breast Cancer Research and Care, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Rossi","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"},{"name":"NSU AutoNation Institute for Breast Cancer Research and Care, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenniffer","family":"Kalil","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"},{"name":"NSU AutoNation Institute for Breast Cancer Research and Care, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4882-5170","authenticated-orcid":false,"given":"Jean J.","family":"Latimer","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"},{"name":"NSU AutoNation Institute for Breast Cancer Research and Care, Nova Southeastern University, Fort Lauderdale, FL 33328, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"ref_1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/35002607","article-title":"The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans","volume":"403","author":"Reinhart","year":"2000","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"bgaf066","DOI":"10.1093\/carcin\/bgaf066","article-title":"microRNA involvement in human cancer","volume":"47","author":"Iorio","year":"2025","journal-title":"Carcinogenesis"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Komatsu, S., Kitai, H., and Suzuki, H.I. (2023). Network Regulation of microRNA Biogenesis and Target Interaction. Cells, 12.","DOI":"10.3390\/cells12020306"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: Biogenesis, function and regulation","volume":"24","author":"Shang","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Plawgo, K., and Raczynska, K.D. (2022). Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs. Noncoding RNA, 8.","DOI":"10.3390\/ncrna8030029"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3390\/cells3040996","article-title":"Regulation of Cardiac Cell Fate by microRNAs: Implications for Heart Regeneration","volume":"3","author":"Andrade","year":"2014","journal-title":"Cells"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Menon, A., Abd-Aziz, N., Khalid, K., Poh, C.L., and Naidu, R. (2022). miRNA: A Promising Therapeutic Target in Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911502"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1002\/1873-3468.15004","article-title":"The role of Lin28A and Lin28B in cancer beyond Let-7","volume":"598","author":"Gariglio","year":"2024","journal-title":"FEBS Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1158\/0008-5472.CAN-11-3864","article-title":"Distinct microRNA expression profiles in prostate cancer stem\/progenitor cells and tumor-suppressive functions of let-7","volume":"72","author":"Liu","year":"2012","journal-title":"Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5769591","DOI":"10.1155\/2018\/5769591","article-title":"The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer","volume":"2018","author":"Mizuno","year":"2018","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"11400","DOI":"10.1073\/pnas.0704372104","article-title":"Let-7 expression defines two differentiation stages of cancer","volume":"104","author":"Shell","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/hum.2008.134","article-title":"let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression","volume":"20","author":"Torrisani","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.cell.2007.10.054","article-title":"let-7 regulates self renewal and tumorigenicity of breast cancer cells","volume":"131","author":"Yu","year":"2007","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature06174","article-title":"Tumor invasion and metastasis initiated by microRNA-10b in breast cancer","volume":"449","author":"Ma","year":"2007","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1158\/0008-5472.CAN-15-0888","article-title":"Combining miR-10b-targeted nanotherapy with low-dose doxorubicin elicits durable regressions of metastatic breast cancer","volume":"75","author":"Yoo","year":"2015","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","article-title":"MicroRNA-21 post-transcriptionally downregulates tumor suppressor PDCD4 and stimulates invasion, intravasation, and metastasis in colorectal cancer","volume":"27","author":"Asangani","year":"2008","journal-title":"Oncogene"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1158\/1078-0432.CCR-12-3325","article-title":"Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth","volume":"19","author":"Leone","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Nguyen, H.T., Kacimi, S.E.O., Nguyen, T.L., Suman, K.H., Lemus-Martin, R., Saleem, H., and Do, D.N. (2021). MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology, 10.","DOI":"10.3390\/biology10050417"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1476-4598-13-184","article-title":"miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma","volume":"13","author":"Cheung","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.gene.2016.08.057","article-title":"MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer","volume":"594","author":"Luo","year":"2016","journal-title":"Gene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","article-title":"Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors","volume":"35","author":"Beg","year":"2017","journal-title":"Investig. New Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/carcin\/bgp219","article-title":"miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer","volume":"30","author":"Gallardo","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"21362","DOI":"10.18632\/oncotarget.15214","article-title":"MicroRNA-34a targets epithelial-to-mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion","volume":"8","author":"Imani","year":"2017","journal-title":"Oncotarget"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Kalfert, D., Ludvikova, M., Pesta, M., Ludvik, J., Dostalova, L., and Kholov\u00e1, I. (2020). Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications. Diagnostics, 10.","DOI":"10.3390\/diagnostics10080563"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"10432","DOI":"10.18632\/oncotarget.3394","article-title":"Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1073\/pnas.0707351104","article-title":"Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells","volume":"104","author":"Tazawa","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13421","DOI":"10.1073\/pnas.0801613105","article-title":"miR-34a repression of SIRT1 regulates apoptosis","volume":"105","author":"Yamakuchi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1038\/cddis.2013.193","article-title":"miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer","volume":"4","author":"Karaayvaz","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_34","first-page":"5777","article-title":"Tumor suppressor function of miR-129-5p in lung cancer","volume":"17","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1002\/ijc.25919","article-title":"Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer","volume":"129","author":"Tsai","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.4161\/cc.9.9.11535","article-title":"miR-129 regulates cell proliferation by downregulating Cdk6 expression","volume":"9","author":"Wu","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7150\/jca.35410","article-title":"MiR-129-5p sensitization of lung cancer cells to etoposide-induced apoptosis by reducing YWHAB","volume":"11","author":"Xu","year":"2020","journal-title":"J. Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1349-7006.2007.00618.x","article-title":"Downregulation of microRNAs-143 and -145 in B-cell malignancies","volume":"98","author":"Akao","year":"2007","journal-title":"Cancer Sci."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Clap\u00e9, C., Fritz, V., Henriquet, C., Apparailly, F., Fernandez, P.L., Iborra, F., Avanc\u00e8s, C., Villalba, M., Culine, S., and Fajas, L. (2009). miR-143 interferes with ERK5 signaling and abrogates prostate cancer progression in mice. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007542"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gregersen, L.H., Jacobsen, A., Frankel, L.B., Wen, J., Krogh, A., and Lund, A.H. (2012). MicroRNA-143 down-regulates hexokinase 2 in colon cancer cells. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-232"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1476-4598-12-77","article-title":"The regulation of toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells","volume":"12","author":"Guo","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/kjm2.12207","article-title":"miR-143 inhibits renal cell carcinoma cells metastatic potential by suppressing ABL2","volume":"36","author":"Xu","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/1476-4598-13-220","article-title":"miR-143 and miR-145 synergistically regulate ERBB3 to suppress cell proliferation and invasion in breast cancer","volume":"13","author":"Yan","year":"2014","journal-title":"Mol. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1038\/onc.2010.386","article-title":"miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness","volume":"29","author":"Mohr","year":"2010","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41419-021-03626-7","article-title":"Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression","volume":"12","author":"Gu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jconrel.2011.06.026","article-title":"Development of microRNA-145 for therapeutic application in breast cancer","volume":"155","author":"Kim","year":"2011","journal-title":"J. Control. Release"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1158\/0008-5472.CAN-09-2021","article-title":"MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1","volume":"70","author":"Sachdeva","year":"2010","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.2147\/CMAR.S300678","article-title":"microRNA-145-5p inhibits migration, invasion, and metastasis in hepatocellular carcinoma by inhibiting ARF6","volume":"13","author":"Wang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"ref_49","first-page":"3171","article-title":"MicroRNA-145 regulates the proliferation, migration and invasion of human primary colon adenocarcinoma cells by targeting MAPK1","volume":"42","author":"Yang","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10120-019-01018-7","article-title":"CircDUSP16 promotes the tumorigenesis and invasion of gastric cancer by sponging miR-145-5p","volume":"23","author":"Zhang","year":"2020","journal-title":"Gastric Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1158\/1078-0432.CCR-20-3139","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo","volume":"27","author":"Anastasiadou","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"ref_52","first-page":"207","article-title":"Prognostic value of miRNA-155 expression in B-cell non-Hodgkin lymphoma","volume":"34","author":"Bedewy","year":"2017","journal-title":"Turk. J. Haematol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Grimaldi, A.M., Nuzzo, S., Condorelli, G., Salvatore, M., and Incoronato, M. (2020). Prognostic and clinicopathological significance of miR-155 in breast cancer: A systematic review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165834"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/or.2013.2576","article-title":"Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1","volume":"30","author":"Huang","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1073\/pnas.0902636106","article-title":"Inositol phosphatase SHIP1 is a primary target of miR-155","volume":"106","author":"Chaudhuri","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1084\/jem.20072108","article-title":"Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder","volume":"205","author":"Rao","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/emmm.200900028","article-title":"Onco-miR-155 targets SHIP1 to promote TNF\u03b1-dependent growth of B cell lymphomas","volume":"1","author":"Pedersen","year":"2009","journal-title":"EMBO Mol. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/bjh.15547","article-title":"Cobomarsen, an oligonucleotide inhibitor of miR-155, coordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma","volume":"183","author":"Seto","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"84508","DOI":"10.18632\/oncotarget.13022","article-title":"MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1210\/jc.2012-3602","article-title":"Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt\/\u03b2-catenin signaling","volume":"98","author":"Zhang","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Castilla, M.\u00c1., D\u00edaz-Mart\u00edn, J., Sarri\u00f3, D., Romero-P\u00e9rez, L., L\u00f3pez-Garc\u00eda, M.\u00c1., Vieites, B., Biscuola, M., Ramiro-Fuentes, S., Isacke, C.M., and Palacios, J. (2012). MicroRNA-200 family modulation in distinct breast cancer phenotypes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047709"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Cavallari, I., Ciccarese, F., Sharova, E., Urso, L., Raimondi, V., Silic-Benussi, M., D\u2019Agostino, D.M., and Ciminale, V. (2021). The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers. Cancers, 13.","DOI":"10.3390\/cancers13235874"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nm.2401","article-title":"Direct targeting of Sec23a  by miR-200s influences cancer cell secretome and promotes metastatic colonization","volume":"17","author":"Korpal","year":"2011","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Lu, Y., Lu, J., Li, X., Zhu, H., Fan, X., Zhu, S., Wang, Y., Guo, Q., Wang, L., and Huang, Y. (2014). MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cells. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-85"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"12215","DOI":"10.2147\/CMAR.S279978","article-title":"MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT","volume":"12","author":"Qian","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1158\/1541-7786.MCR-10-0497","article-title":"miR-200 inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1\/VEGFR1","volume":"9","author":"Roybal","year":"2011","journal-title":"Mol. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1158\/0008-5472.CAN-13-0297","article-title":"miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer","volume":"73","author":"Cai","year":"2013","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2353\/ajpath.2009.080731","article-title":"Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma","volume":"174","author":"Childs","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/bjc.2013.131","article-title":"miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients","volume":"108","author":"Hagman","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e2291","DOI":"10.1038\/cddis.2016.194","article-title":"miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer","volume":"7","author":"Hu","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-08-2920","article-title":"microRNA-205 regulates HER3 in human breast cancer","volume":"69","author":"Iorio","year":"2009","journal-title":"Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1200\/JCO.2008.19.4134","article-title":"Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma","volume":"27","author":"Lebanony","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3892\/or.2013.2755","article-title":"miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN","volume":"30","author":"Lei","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4161\/cc.11.4.19228","article-title":"MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN","volume":"11","author":"Qu","year":"2012","journal-title":"Cell Cycle"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/ijc.25461","article-title":"Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer","volume":"128","author":"Wiklund","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/cr.2009.18","article-title":"Suppression of cell growth and invasion by miR-205 in breast cancer","volume":"19","author":"Wu","year":"2009","journal-title":"Cell Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12672-010-0043-5","article-title":"MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer","volume":"1","author":"Cochrane","year":"2010","journal-title":"Horm. Cancer"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/djq102","article-title":"MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer","volume":"102","author":"Gasparini","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3892\/etm.2023.11826","article-title":"MiR-221 and miR-222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3","volume":"25","author":"Kim","year":"2023","journal-title":"Exp. Ther. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/sj.emboj.7601790","article-title":"Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation","volume":"26","author":"Nagel","year":"2007","journal-title":"EMBO J."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41523-018-0073-7","article-title":"MiR-221\/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines","volume":"4","author":"Liang","year":"2018","journal-title":"NPJ Breast Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"580","DOI":"10.18632\/oncotarget.5979","article-title":"MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b","volume":"7","author":"Roscigno","year":"2016","journal-title":"Oncotarget"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"ra1","DOI":"10.1126\/scisignal.2001538","article-title":"TRPS1 targeting by miR-221\/222 promotes the epithelial-to-mesenchymal transition in breast cancer","volume":"4","author":"Stinson","year":"2011","journal-title":"Sci. Signal."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"268","DOI":"10.5483\/BMBRep.2014.47.5.165","article-title":"MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN","volume":"47","author":"Ye","year":"2014","journal-title":"BMB Rep."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Zhang, C.Z., Han, L., Zhang, A.L., Fu, Y.C., Yue, X., Wang, G.X., Jia, Z.F., Pu, P.Y., Zhang, Q.Y., and Kang, C.S. (2010). MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-367"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"23716","DOI":"10.1074\/jbc.M701805200","article-title":"miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1","volume":"282","author":"Galardi","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Mercatelli, N., Coppola, V., Bonci, D., Miele, F., Costantini, A., Guadagnoli, M., Bonanno, E., Muto, G., Frajese, G.V., and De Maria, R. (2008). The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0004029"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1677\/ERC-07-0129","article-title":"MicroRNAs miR-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle","volume":"14","author":"Visone","year":"2007","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_90","first-page":"893","article-title":"MiR-222 overexpression promotes proliferation of human hepatocellular carcinoma HepG2 cells by downregulating p27","volume":"7","author":"Yang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Xiao, J., Zhang, L., Su, R., Zhao, B., Dang, Y., Zhao, C., Wang, S., Qi, T., and Ji, F. (2025). MicroRNAs in breast cancer\u2014New frontiers in diagnosis, targeted therapy, and prognosis assessment. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1529907"},{"key":"ref_93","first-page":"3575","article-title":"miR-145 suppresses ovarian cancer progression via modulation of cell growth and invasion by targeting CCND2 and E2F3","volume":"19","author":"Hua","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1158\/1541-7786.MCR-13-0419","article-title":"miR-21 Targets 15-PGDH and Promotes Cholangiocarcinoma Growth","volume":"12","author":"Lu","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Seyhan, A.A. (2024). Trials and Tribulations of MicroRNA Therapeutics. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031469"},{"key":"ref_96","first-page":"1290","article-title":"In vivo and in vitro impact of miR-31 and miR-143 on the suppression of metastasis and invasion in breast cancer","volume":"23","author":"Soheilyfar","year":"2018","journal-title":"J. BUON"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/onc.2009.106","article-title":"The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells","volume":"28","author":"Kato","year":"2009","journal-title":"Oncogene"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"888","DOI":"10.62347\/NPLT8946","article-title":"MiR-145-5p inhibits proliferation of hepatocellular carcinoma, acting through PAI-1","volume":"17","author":"Li","year":"2025","journal-title":"Am. J. Transl. Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.3892\/ol.2016.5372","article-title":"miRNA-129-5p suppresses cell proliferation and invasion in lung cancer by targeting microspherule protein 1, E-cadherin and vimentin","volume":"12","author":"Zhang","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Pagoni, M., Cava, C., Sideris, D.C., Avgeris, M., Zoumpourlis, V., Michalopoulos, I., and Drakoulis, N. (2023). miRNA-Based Technologies in Cancer Therapy. J. Pers. Med., 13.","DOI":"10.3390\/jpm13111586"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.gene.2018.09.011","article-title":"Hyperoside and let-7a-5p synergistically inhibits lung cancer cell proliferation via inducing G1\/S phase arrest","volume":"679","author":"Li","year":"2018","journal-title":"Gene"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1016\/j.ymthe.2022.07.015","article-title":"Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics","volume":"30","author":"Yuen","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/acs.molpharmaceut.5b00756","article-title":"Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer","volume":"13","author":"Dai","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.18632\/oncotarget.23414","article-title":"Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1","volume":"9","author":"Fesler","year":"2018","journal-title":"Oncotarget"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.omtn.2019.11.010","article-title":"Functional significance and therapeutic potential of miR-15a mimic in pancreatic ductal adenocarcinoma","volume":"19","author":"Guo","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.18632\/oncotarget.22322","article-title":"Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.omto.2023.02.007","article-title":"Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer","volume":"28","author":"Hwang","year":"2023","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.febslet.2014.02.054","article-title":"MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer","volume":"588","author":"Qiu","year":"2014","journal-title":"FEBS Lett."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Dasgupta, I., and Chatterjee, A. (2021). Recent Advances in miRNA Delivery Systems. Methods Protoc., 4.","DOI":"10.3390\/mps4010010"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejpb.2008.09.019","article-title":"Recent development of nonviral gene delivery systems with virus-like structures and mechanisms","volume":"71","author":"Itaka","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/mt.2011.48","article-title":"Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice","volume":"19","author":"Trang","year":"2011","journal-title":"Mol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/dna.2015.2800","article-title":"Establishment of lipofection protocol for efficient miR-21 transfection into cortical neurons in vitro","volume":"34","author":"Han","year":"2015","journal-title":"DNA Cell Biol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1021\/acs.jmedchem.4c00802","article-title":"Structure\u2013activity relationship of antibody\u2013oligonucleotide conjugates: Evaluating bioconjugation strategies for antibody\u2013siRNA conjugates for drug development","volume":"67","author":"Cochran","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/s12276-024-01201-6","article-title":"Recent advances in extracellular vesicles for therapeutic cargo delivery","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41392-024-02035-4","article-title":"Nucleic acid drugs: Recent progress and future perspectives","volume":"9","author":"Sun","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7677","DOI":"10.1021\/jacs.3c00841","article-title":"Aptamer-based targeted delivery of functional nucleic acids","volume":"145","author":"Xie","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/nar\/26.9.2224","article-title":"Advantages of 2\u2032-O-methyl oligoribonucleotide probes for detecting RNA targets","volume":"26","author":"Majlessi","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"ref_120","first-page":"7027","article-title":"3\u2032-Terminal 2\u2032-O-methylation of lung cancer miR-21-5p enhances its stability and association with Argonaute 2","volume":"48","author":"Liang","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt.3948","article-title":"Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides","volume":"35","author":"Iwamoto","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Caglayan, S., Hansen, J.B., and Snir, O. (2023). Optimized workflow to modify microRNA expression in primary human intravascular cells. BMC Immunol., 24.","DOI":"10.1186\/s12865-023-00540-9"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/nat.2011.0332","article-title":"A locked nucleic acid oligonucleotide targeting microRNA 122 is well-tolerated in cynomolgus monkeys","volume":"22","author":"Aarup","year":"2012","journal-title":"Nucleic Acid Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/ilar\/ilx028","article-title":"The chimpanzee model of viral hepatitis: Advances in understanding the immune response and treatment of viral hepatitis","volume":"58","author":"Lanford","year":"2017","journal-title":"ILAR J."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-025-03391-x","article-title":"MicroRNA in cancer therapy: Breakthroughs and challenges in early clinical applications","volume":"44","author":"Tagliaferri","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:03:14Z","timestamp":1784890994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/8\/1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":127,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["biom16081086"],"URL":"https:\/\/doi.org\/10.3390\/biom16081086","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}